30day notice

77872

Federal Register / Vol. 89, No. 185 / Tuesday, September 24, 2024 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of
respondents

Form name

Type of respondent

Data Management and Sharing Plan ...................
VCOC Certification ...............................................
SBIR/STTR Funding Agreement Certification ......

Grant Applicant .............
Grant Applicant .............
Grant Applicant .............

Number of
responses per
respondent

73,117
6
1,500

Average
burden per
response
(in hours)

Total annual
burden hours

1
1
1

2
5/60
15/60

146,234
1
375

PHS Fellowship—Electronic
PHS Fellowship Supplemental Form (includes F
reference letters).
Biosketch (Fellowship) ..........................................
416–1 ....................................................................
PHS 416–5 ...........................................................
PHS 6031 .............................................................

Fellowship
cant.
Fellowship
cant.
Fellowship
cant.
Fellowship
cant.
Fellowship
cant.

Grant Appli-

6,707

1

13

87,191

Grant Appli-

6,707

1

2

13,414

Grant Appli-

29

1

10

290

Grant Appli-

6,707

1

5/60

559

Grant Appli-

6,217

1

5/60

518

239

1

11

2,629

486,749

486,749

........................

2,175,670

NIH Other Transaction
NIH Other Transaction Application Form .............
Total ...............................................................

Dated: September 16, 2024.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes
of Health.
[FR Doc. 2024–21801 Filed 9–23–24; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health

lotter on DSK11XQN23PROD with NOTICES1

National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Cystic Fibrosis
Research and Translation Centers.
Date: October 31–November 1, 2024.
Time: 9:30 a.m. to 6:00 p.m.

VerDate Sep<11>2014

18:07 Sep 23, 2024

Jkt 262001

Other Transaction Applicant.
.......................................

Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
NIDDK, Democracy II, Suite 7000A, 6707
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Ryan G. Morris, Ph.D.,
Scientific Review Officer, National Institute
of Diabetes and Digestive and Kidney
Diseases, National Institutes of Health, 6707
Democracy Boulevard, Rm 7015, Bethesda,
MD 20892–2542, 301–594–4721,
[email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: September 18, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–21739 Filed 9–23–24; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; Post-Award
Reporting Requirements Including
Research Performance Progress
Report Collection (Office of the
Director)
AGENCY:

National Institutes of Health,

HHS.

PO 00000

Frm 00062

Fmt 4703

Sfmt 4703

ACTION:

Notice.

In compliance with the
requirement of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30-days of the date of this
publication.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments, submit
comments in writing, or request more
information on the proposed project,
contact: Ms. Mikia P. Currie, Program
Analyst, Office of Policy for Extramural
Research Administration, 6705
Rockledge Drive, Suite 350, Bethesda,
Maryland 20892, or call a non-toll-free
number 301–435–0941 or email your
request, including your address to
[email protected].
Formal requests for additional plans and
SUMMARY:

E:\FR\FM\24SEN1.SGM

24SEN1

77873

Federal Register / Vol. 89, No. 185 / Tuesday, September 24, 2024 / Notices
instruments must be requested in
writing.
This
proposed information collection was
previously published in the Federal
Register on May 22, 2024, pages 45000–
45001 (89 FR 45000) and allowed 60
days for comment. One public comment
was received. The purpose of this notice
is to allow an additional 30 days for
public comment.
The Office of the Director (OD), Office
of Extramural Research (OER), National
Institutes of Health (NIH), may not
conduct or sponsor, and the respondent
is not required to respond to, an
information collection that has been
extended, revised, or implemented on or
after October 1, 1995, unless it displays
a currently valid Office of Management
and Budget (OMB) control number.
In compliance with section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, NIH has
submitted to OMB a request for review
and approval of the information
collection listed below.
Proposed Collection Title: Public
Health Service (PHS) Post-award
Reporting Requirements Revision, OMB
0925–0002, Expiration Date 01/31/2026,
Office of the Director (OD), National
Institutes of Health (NIH).
Need and Use of Information
Collection: Starting in Fiscal Year 2025,
NIH will require applicable recipients to
address progress in association with
their approved Data Management and
Sharing (DMS) Plans within the
Research Performance Progress Report

SUPPLEMENTARY INFORMATION:

(RPPR) in accordance with the final NIH
Policy for Data Management and
Sharing (DMS Policy) to promote the
management and sharing of scientific
data generated from NIH-funded or
conducted research. The progress report
forms will be updated to align with this
requirement. The Training Data Tables
will also be updated to reduce burden
and promote consistent information
collection, including limiting the scope
of information collection to data only
relevant to the training stage(s) of the
proposed program in table 1 and
removing instructions in table 8 that are
reported within the RPPR. Effective for
May 2025, NIH will be adopting the
Common Forms for Biographical Sketch
and Current and Pending (Other)
Support as part of the directive from
Guidance for Implementing National
Security Presidential Memorandum-33.
The Common Forms are part of a
separate OMB collection, currently
approved under 3145–0279 (Expiration
Date 10/31/2026). As such, elements
that will be collected within the
Common Forms will be removed from
NIH’s current NIH Biosketch and Other
Support formats. NIH will continue to
collect additional information not
captured on the Common Forms to
adhere to the agency’s implementation
of the NIH Peer Review Regulations at
42 CFR part 52 as part of the NIH
Biosketch form, which will be renamed
the NIH Biographical Sketch
Supplement to reflect the supplemental
information requested. The application
and progress report forms and
associated instructions will be updated

to align with these new requirements.
The RPPR is required to be used by all
NIH, Food and Drug Administration,
Centers for Disease Control and
Prevention, and Agency for Healthcare
Research and Quality recipients. Interim
progress reports are required to continue
support of a PHS grant for each budget
year within a competitive segment. This
collection also includes other PHS postaward reporting requirements: PHS
416–7 National Research Service Award
(NRSA) Termination Notice, PHS 2271
Statement of Appointment, 6031–1
NRSA Annual Payback Activities
Certification, Department of Health and
Human Services (HHS) 568 Final
Invention Statement and Certification,
and PHS 3734 Statement Relinquishing
Interests and Rights in a PHS Research
Grant. The PHS 416–7, 2271, and 6031–
1 is used by NRSA recipients to activate,
terminate, and provide for payback of a
NRSA. Closeout of an award requires a
Final Invention Statement (HHS 568)
and Final Progress Report. The PHS
3734 serves as the official record of
recipient relinquishment of a PHS
award when an award is transferred
from one recipient institution to
another. Pre-award reporting
requirements are simultaneously
consolidated under 0925–0001 and the
changes to the collection here are
related.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
629,463.

ESTIMATED ANNUALIZED BURDEN HOURS
Form name

Number of
respondents

Type of respondent

Number of
responses per
respondent

Average
burden per
response
(in hours)

Total annual
burden hours

lotter on DSK11XQN23PROD with NOTICES1

Reporting
PHS 416–7 ...........................................................
PHS 6031–1 .........................................................
PHS 568 ...............................................................
PHS 2271 .............................................................
PHS 2590 .............................................................
RPPR—Core Data ................................................
Biosketch (Part of RPPR) .....................................
Data Tables (Part of RPPR) .................................
Trainee Diversity Report (Part of RPPR) .............
PHS Human Subjects and Clinical Trial Information.
Publication Reporting ............................................
Final RPPR—Core Data .......................................
Data Tables (Part of Final RPPR) ........................
Trainee Diversity Report (Part of Final RPPR) ....
PHS Human Subjects and Clinical Trial Information (Part of Final RPPR).
PHS 3734 .............................................................
Data Management and Sharing Plan (Part of
RPPR).

VerDate Sep<11>2014

18:07 Sep 23, 2024

Jkt 262001

Recipient
Recipient
Recipient
Recipient
Recipient
Recipient
Recipient
Recipient
Recipient
Recipient

.......................
.......................
.......................
.......................
.......................
.......................
.......................
.......................
.......................
.......................

12,580
1,778
11,180
22,035
243
32,098
2,544
758
480
6,420

1
1
1
1
1
1
1
1
1
1

30/60
20/60
5/60
15/60
18
9
2
4
15/60
3

6,290
593
932
5,509
4,374
288,882
5,088
3,032
120
25,680

Recipient
Recipient
Recipient
Recipient
Recipient

.......................
.......................
.......................
.......................
.......................

97,023
18,000
758
480
3,600

3
1
1
1
1

5/60
11
4
15/60
4

24,256
198,000
3,032
120
14,400

Recipient .......................
Recipient .......................

479
15,649

1
1

30/60
2

240
31,298

PO 00000

Frm 00063

Fmt 4703

Sfmt 4703

E:\FR\FM\24SEN1.SGM

24SEN1

77874

Federal Register / Vol. 89, No. 185 / Tuesday, September 24, 2024 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of
responses per
respondent

Number of
respondents

Average
burden per
response
(in hours)

Total annual
burden hours

Form name

Type of respondent

Data Management and Sharing Plan (Part of
Final RPPR).

Recipient .......................

8,621

1

2

17,242

Reporting Burden Total .................................

.......................................

........................

........................

........................

629,088

Recording Keeping
SBIR/STTR Life Cycle Certification ......................

Recipient .......................

1,500

1

15/60

375

Grand Total ....................................................

.......................................

236,226

430,272

........................

629,463

Dated: September 16, 2024.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes
of Health.
[FR Doc. 2024–21802 Filed 9–23–24; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting

lotter on DSK11XQN23PROD with NOTICES1

Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the NIH Clinical Center
Research Hospital Board.
This will be a hybrid meeting held inperson and virtually and will be open to
the public as indicated below.
Individuals who plan to attend inperson or view the virtual meeting and
need special assistance or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The meeting
can be accessed from the NIH Videocast
at the following link: https://
videocast.nih.gov/.
Name of Committee: NIH Clinical Center
Research Hospital Board.
Date: October 18, 2024.
Time: 9:00 a.m. to 1:00 p.m.
Agenda: NIH and Clinical Center (CC)
Leadership Announcements, CC CEO Update
of Recent Activities and Organizational
Priorities, Status Report on Key CC Strategic
Plan Initiatives, and Other Business of the
Clinical Center Research Hospital Board
(CCRHB).
Place: National Institutes of Health,
Building 31, Conference Room 6C02 A & B,
9000 Rockville Pike, Bethesda, MD 20892 (InPerson and Virtual)
Contact Persons:
Patricia Piringer, RN, MSN (C), National
Institutes of Health Clinical Center, 10 Center
Drive, Bethesda, MD 20892 ppiringer@
cc.nih.gov, (301) 402–2435, (202) 460–7542
(direct).

VerDate Sep<11>2014

18:07 Sep 23, 2024

Jkt 262001

Natascha Pointer, Management Analyst,
Executive Assistant to Dr. Gilman Office of
the Chief Executive Officer, National
Institutes of Health Clinical Center, 10 Center
Drive, Bethesda, MD 20892, npointer@
cc.nih.gov, (301) 496–4114, (301) 402–2434
(direct).
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person(s) listed
on this notice. The statement should include
the name, address, telephone number and,
when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors attending a meeting on
campus or at an off-campus federal facility
will be asked to show one form of
identification (for example, a governmentissued photo ID, driver’s license, or passport)
and to state the purpose of their visit.
Information is also available on the CCRHB
website: https://www.ccrhb.od.nih.gov/
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

Dated: September 19, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.

Dated: September 18, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.

[FR Doc. 2024–21838 Filed 9–23–24; 8:45 am]

[FR Doc. 2024–21738 Filed 9–23–24; 8:45 am]

BILLING CODE 4140–01–P

BILLING CODE 4140–01–P

PO 00000

Frm 00064

Fmt 4703

Sfmt 9990

National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Palliative
Care Research Consortium.
Date: November 7, 2024.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging, 5601
Fishers Lane, Rockville, MD 20892 (Virtual
Meeting).
Contact Person: Janetta Lun, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institutes of Health, 5601
Fishers Lane, Rm. 213, Rockville, MD 20814,
(301) 496–9666, [email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)

E:\FR\FM\24SEN1.SGM

24SEN1